Filing Details
- Accession Number:
- 0001689375-24-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-20 17:21:58
- Reporting Period:
- 2024-05-16
- Accepted Time:
- 2024-05-20 17:21:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689375 | Entrada Therapeutics Inc. | TRDA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1613084 | Dipal Doshi | C/O Entrada Therapeutics, Inc. One Design Center Place, Suite 17-500 Boston MA 02210 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-05-16 | 1,800 | $15.00 | 338,575 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-05-17 | 1,200 | $15.11 | 337,375 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.